| Title |
The Cost Effectiveness of Long-Acting/Extended-Release Antipsychotics for the Treatment of Schizophrenia
|
|---|---|
| Published in |
Applied Health Economics and Health Policy, March 2013
|
| DOI | 10.1007/s40258-013-0016-2 |
| Pubmed ID | |
| Authors |
Evanthia Achilla, Paul McCrone |
| Abstract |
Antipsychotic medication is the mainstay of treatment in schizophrenia. Long-acting medication has potential advantages over daily medication in improving compliance and thus reducing hospitalization and relapse rates. The high acquisition and administration costs of such formulations raise the need for pharmacoeconomic evaluation. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| New Zealand | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 1% |
| United Kingdom | 1 | <1% |
| Unknown | 140 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 20% |
| Student > Master | 22 | 15% |
| Student > Ph. D. Student | 17 | 12% |
| Student > Bachelor | 15 | 10% |
| Other | 9 | 6% |
| Other | 21 | 15% |
| Unknown | 30 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 24% |
| Psychology | 20 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 8% |
| Nursing and Health Professions | 9 | 6% |
| Social Sciences | 8 | 6% |
| Other | 26 | 18% |
| Unknown | 34 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2013.
All research outputs
#18,332,122
of 22,701,287 outputs
Outputs from Applied Health Economics and Health Policy
#591
of 767 outputs
Outputs of similar age
#149,047
of 196,101 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#10
of 12 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 767 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,101 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.